NEW HAVEN — Alexion Pharmaceuticals’ decision to move its global headquarters to New Haven will relocate an existing workforce of more than 350 employees to the Elm City, and also add up to 300 new jobs in Connecticut, according to the governor’s office. Having outgrown its current Cheshire space, the company plans to build a new facility in New Haven’s Downtown Crossing development at 100 College Street. Winstanley Enterprises is helming the $100 million construction project, which will include office, research retail and parking space. Alexion’s move was precipitated by Gov. visit us P. Malloy’s “First Five” program, which offers incentive packages of grants, low-interest loans and tax credits to companies agreeing to create significant numbers of jobs.
|< Prev||Next >|